IL10 and arthritic joint disease: PDRN was evaluated in collagen-induced arthritis: in this experimental paradigm, PDRN was shown to improve clinical signs of arthritis, reduce histological damage and decrease the amount of several pro-inflammatory cytokines both in cartilage and blood, while increasing the expression of anti-inflammatory cytokines such as interleukin-10 (IL-10) (Figure 1).